Skip to main content
OpenTrials
Completed

NCT Number: NCT04603677

Northern Colorado COVID-19 Biobank

The NoCo-CoBio Project is a biobanking effort to store and preserve saliva, nasopharyngeal, stool and blood specimens from SARS-CoV-2 PCR (polymerase chain reaction) positive individuals.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Covid19 COVID-19 Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Colorado State University, Fort Collins, Colorado, United States

Loading trial locations.

About this study

The investigators have created a biorepository of stool, saliva, nasopharyngeal swab specimens, peripheral blood mononuclear cells, serum, and plasma from SARS-CoV-2 infected individuals for research purposes. The multifaceted biorepository will be used to establish markers predicting various presentations of COVID-19 (coronavirus disease 2019).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Those who have had a positive SARS-CoV-2 PCR test

Exclusion criteria

  • under 18 years of age
  • pregnant

Treatment and study plan

Primary outcomes

  1. Evaluation of parameters for markers of SARS-CoV-2 infection and predictors for severe disease

    Time frame: 6 months

    Evaluation of parameters for markers of SARS-CoV-2 infection and predictors for severe disease

Secondary outcomes

  1. Evaluation of markers and predictors of post acute sequelae of COVID-19

    Time frame: 2 years

    Evaluation of markers and predictors of post acute sequelae of COVID-19

Sponsors and collaborators

Lead sponsor

Colorado State University

Other

Collaborators

  • University of Colorado Health

Registry information

Official study title

Northern Colorado Coronavirus Biobank: A Biorepository for Acute and Convalescent Patient Samples From Coloradoans Infected With SARS-CoV-2 (Severe Acute Respiratory Syndrome-Coronavirus-2)

Acronym: NoCo-CoBio

Important dates

Study start
2020
Primary completion
2023
Study completion
2023
First posted
Oct 27, 2020
Registry last updated
Mar 21, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.